@article{b4a2ccd211984d9f8c045a75397bcc28,
title = "Coapting Cost and Clinical Outcomes in Transcatheter Intervention for Secondary Mitral Regurgitation",
keywords = "Editorials, cost effeciveness, heart failure, mitral valve insufficiency, replacement, ventricular remodeling",
author = "Bonow, {Robert O.} and Mark, {Daniel B.} and O'Gara, {Patrick T.}",
note = "Funding Information: Dr Mark reports grants from Eli Lilly & Company, Gilead, AstraZeneca, Bristol Myers Squibb, Merck & Company, and Oxygen Therapeutics and consulting fees from Medtronic and Janssen, outside the submitted work. The other authors report no conflicts.",
year = "2019",
month = dec,
day = "3",
doi = "10.1161/CIRCULATIONAHA.119.043408",
language = "English (US)",
volume = "140",
pages = "1892--1894",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "23",
}